Intratumoral delivery of TransCon (TM) TLR7/8 Agonist provides potent anti-tumor activity as a monotherapy and in combination with IL-2 while minimizing systemic cytokine induction
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要